Introducing the “What Does the Evidence Say About COVID-19?” Portal In April 2020, we launched our CADTH COVID-19 web portal to provide Canadian health care decision-makers with the most relevant and timely evidence about COVID-19. This special site features evidence, tools, and resources from CADTH and other trusted sources that covered a range of COVID-19 topics, including prevention, testing, and treatment. It was continually updated and expanded throughout the year […]

Uncovering Whether the Evidence Supports the Hype Around Antiviral Treatments for COVID-19 In May 2020, we launched our COVID-19 Webinar series. More than 1,500 people registered for the first webinar, which featured Dr. Gordon Guyatt, Distinguished Professor at McMaster University, and Dr. Tarry Ahuja, Manager of Program Development at CADTH. Dr. Guyatt discussed “Treatment of Patients With Nonsevere and Severe Coronavirus Disease 2019: An Evidence-Based Guideline,” which had been recently […]

Collaborating With the Canadian Association of Radiologists to Help Address COVID-19 Restrictions on Medical Imaging Services In the summer of 2020, as COVID-19 restrictions were loosening, governments began to consider how to safely resume medical imaging procedures and address the significant patient wait lists that resulted from the pandemic. During this time, we joined a pan-Canadian Radiology Re-entry Taskforce to provide guidance to Canadian health care systems on how best […]

Aligning the Reimbursement Review Processes In September 2020, we took a significant step forward in making its Reimbursement Review program more cohesive, transparent, and responsive by establishing a harmonized review process for drugs submitted to CADTH for assessment. Previously, there were different procedures for each of our review pathways: Common Drug Review, pan-Canadian Oncology Drug Review, and Interim Plasma Protein Product Review. Today, there is a single procedure that incorporates […]

Recognizing Outstanding Leaders in Health Technology Assessment In November 2020, we presented Dr. Wendy Ungar with the 2020 Dr. Jill M. Sanders Award of Excellence and Dr. Kelvin Chan with the Dr. Maurice McGregor Award. The Jill M. Sanders Award of Excellence honours individuals whose outstanding achievements have significantly advanced health technology assessment in Canada. The Dr. Maurice McGregor Award honours rising stars early in their health technology assessment careers. […]

Updating the Patient Input Guide Through Consultations In December 2020, we released our updated Guidance for Providing Patient Input. The guide is a key resource for patient groups, patients, and caregivers who contribute to the CADTH Reimbursement Review process. We updated the guide with help from feedback from more than 35 patient groups. Key improvements suggested by patient groups included: expanding the definition of a “patient group” and outlining patient […]

Launching the Canadian Journal of Health Technologies In January 2021, we launched the Canadian Journal of Health Technologies. This open-access journal provides CADTH with an online presence to showcase our wide-ranging scientific reports and make our reports more accessible to the Canadian and global health technology assessment community. Improved searching and indexing via PubMed and Google Scholar, standardized formats, and a continuous publication model in which reports are published as […]

Showcasing 2021 Health Technology Trends on CADTH’s Watch List On February 17, 2021, we published our list of Health Technology Trends to Watch. Included in this report were 10 emerging health technology trends poised to have a significant influence on the future of health care in Canada that we identified through our Horizon Scanning program. Artificial intelligence, connected devices, and COVID-19 home sampling were among the trends expected to gain […]

Developing Our First Condition-Level Review on Tuberculosis Care In March 2021, on World Tuberculosis Day, we launched our first condition-level review on tuberculosis, one of the world’s most infectious diseases. Tuberculosis is a highly preventable disease that disproportionately affects communities experiencing higher rates of poverty, crowded living conditions, and poor access to health care. Through a digital platform on the CADTH website, we have been able to support Canadian health […]

Partnering With Choosing Wisely Canada In March 2021, under the leadership of CADTH’s Executive Strategy Lead, Heather Logan, we partnered with Choosing Wisely Canada to identify actions that could lead to better post-pandemic health care for Canadians. Throughout the COVID-19 pandemic, the effects of delayed non-urgent care and elective procedures were a top concern of patients, health care professionals, and policy-makers. As our health systems began to reopen, it was […]